Ознакомительная версия. Доступно 17 страниц из 84
Food and Drug Administration, Trans fat at-a-glance. Siehe http://ww.fda.gov/Food/IngredientsPackingLabeling/LabelingNutrition/ucm079609.htm. Abgerufen Juli 2018.
67 Willett, Walter, Eat, Drink and Be Healthy: The Harvard Medical School Guide to Healthy Eating, New York: Free Press 2001.
68 Kavanagh, K. et al., Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring) 15 (7): 1675 – 1684, 2007.
69 Harvard School of Public Health, «Shining the spotlight on transfats». Siehe http://hsph.harvard.edu/nutritionsource/transfats. Abgerufen August 2018.
70 Ascherio, A. et al., Trans fatty acids and coronary heart disease. N Engl J Med 340 (25): 1994 – 1998, 1999.
71 Walling, Elizabeth, A Real Killer: Trans Fat Causes Colon Cancer. Natural News 2009, siehe https://www.naturalnews.com/025960_trans_fat_food_cancer.html. Abgerufen September 2018.
72 Chajès, V. et al., Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 167 (11): 1312 – 1320, 2008.
73 2015 Dietary Guidelines Advisory Committee, Scientific report of the 2015 Dietary Guidelines Advisory Committee. Siehe http://www.health.gov/dietaryguidelines/2015-scientific-report/. Abgerufen August 2018.
74 Ramsden, C. E. et al., N-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-ana398lysis of randomised controlled trials. Br J Nutr 104 (11): 1586 – 1600, 2010.
75 Simopoulos, A. P., Evolutionary aspects of diet, the omega-6/omega-3ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60 (9): 502 – 507, 2006.
76 Yancy, W. S. Jr et al., A low-carbohydrate, ketogenic diet versus a lowfat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern. Med 140 (10): 769 – 777, 2004.
77 Calder, P. C., The American Heart Association advisory on n-6 fatty acids: evidence based or biased evidence? Br J Nutr 104 (11): 1575 – 1576, 2010.
78 Hibbeln, Joseph R. et al., Increasing homicide rates and linoleic acid consumption among five Western countries, 1961 – 2000. Lipids 39: 1207 – 1213, 2004.
79 Fallon, Sally/Enig, Mary G., The great Con-ola. 2002. Siehe http://www.westonaprice.org/health-topics/the-great-con-ola/. Abgerufen August 2018.
80 Silbernagl, Stefan/Despopoulos, Agamemnon/Draghun, Andras (Hg.), Taschenatlas Physiologie. 9. Auflage, Stuttgart: Thieme 2018.
81 Weston A. Price Foundation, Know your fats introduction. 2009. Siehe http://www.westonaprice.org/Health-topics/know-your-fats-introduction/. Abgerufen September 2018.
82 Opara, E. C. et al., Effects of fatty acids on insulin release: role of chain length and degree of saturation. Am J Physiol 266: E 635 – 639, 1994.
83 Lane, N., Power, sex, suicide: Mitochondria and the meaning of life. New York: Oxford University Press 2006.
84 Kuklinski, Bodo/Schemionek, Anja, Mitochodrientherapie – die Alternative. 5. Auflage, Bielefeld: Aurum Verlag 2016.
85 Wer dieses Thema vertiefen möchte, dem empfehle ich mein Buch Schlank und gesund mit der Doc Fleck Methode, Hilden: BJV Verlag 2017.
86 Pomplun, D. et al., Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proceedings of the National Academy of Sciences (USA) 104 (15): 6377 – 6381, 2007.
87 Cypess, A. M. et al., Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360 (15): 1509 – 1517, 2009; Saito, M. et al., High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58 (7): 1526 – 1531, 2009; Van Marken Lichtenbelt, W. D. et al., 399 Cold-activated brown adipose tissue in healthy men. N Engl J Med 360 (15): 1500 – 1508, 2009; Virtanen, K. A. et al., Functional brown adipose tissue in healthy adults. N Engl J Med 360 (15): 1518 – 1525, 2009.
88 Christen, William G. et al., Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol 129 (7): 921 – 929, 2011.
89 Georgiou, T./Prokopiou, E., The new era of omega-3 fatty acids supplementation: therapeutic effects on dry age-related macular degeneration. J Stem Cells 10 (3): 205 – 215, 2015.
90 Jelinek, G. A. et al., Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci 123 (11): 792 – 800, 2013.
91 Nordvik, I. et al., Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102 (3): 143 – 149, 2000.
92 Perera, H. et al., Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. J Child Neurol 27 (6): 747 – 753, 2012.
93 Bickel, H., Demenzsyndrom und Alzheimer Krankheit: Eine Schätzung des Krankenbestandes und der jährlichen Neuerkrankungen in Deutschland. Gesundheitswesen 62 (4): 211 – 218, 2000.
94 Riedel-Heller, S. G. et al., Recruitment procedures and their impact on the prevalence of dementia. Neuroepidemiology 19: 130 – 140, 2000.
95 Möller, T., Borne, C., Reiser, M. et al., Alzheimer Krankheit und vaskuläre Demenz Bd. 5, Springer Verlag Wien, 54 – 61, 2009.
96 Wancata, J. et al., Number of dementia sufferers in Europe between the years 2000 and 2050. Eur Psychiatry 18 (6): 306 – 313, 2003.
97 De la Monte, S. M., Insulin resistance and Alzheimer’s disease. BMB Reports 42 (8): 475 – 481, 2009.
98 Robers, R. O. et al., Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. J Alzheimer’s Dis 32 (2): 329 – 39, 2012.
99 Henderson, Samuel T. et al., Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutrition&Metabolism 6: 31, 2006.
100 Mercola, Fat for fuel. 400
101 Wheless, J. W., History of the ketogenic diet. Epilepsias 49 Suppl. 8: 3 – 5, 2008.
102 Martin, K. et al., Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Systematic Reviews 2016, 2.
103 DeGiorgio, C. M. et al., Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. J Neurol Neurosurg Psychiatry 86 (1): 65 – 70, 2015.
104 Reda, D. M. et al., Fish Oil Intake and Seizure Control in Children with Medically Resistant Epilepsy. N Am J Med Sci. 7 (7): 317 – 21, 2015.
105 Cromie, William J., Discovering what lives in your mouth. Harvard University Gazette, 22. August 2002.
106 Hughes, R. A., Focal infection revisited. Br J Rheumatol 33 (4): 370 – 77, 1994.
107 Kuklinski/Scheminonek, Mitochondrientherapie.
108 Philstrom et al., Lancet, Volume 366, Issue 9499, November
Ознакомительная версия. Доступно 17 страниц из 84
